Pemphigoid, Bullous: all 64 studies
Page 1 of 1. Open to participants first (8), then studies with results posted, then the rest; newest registration first within each.
- Study of Stapokibart Injection in Subjects With Moderate to Severe Bullous PemphigoidNot yet recruitingNCT07210554Phase 3
- Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)Enrolling by invitationNCT06723106Phase 1
- Deciphering IL-17-dependant Inflammatory Response in Bullous PemphigoidRecruitingNCT06479018Not applicable
- Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)RecruitingNCT06371417Phase 1
- Retrospective Study of the Effects of Sub-pathologic Phenotypes of BP on Clinical Management and PrognosisRecruitingNCT06213909
- Screening for Adrenal Insufficiency During Dermocorticoid Reduction in Bullous Pemphigoid (BP)RecruitingNCT06148090Not applicable
- Validation of a Simplified Severity Score (Investigator Global Assessment: IGA) in Bullous PemphigoidNot yet recruitingNCT05366127
- Autoimmune Blistering Diseases StudyRecruitingNCT02753777
- A Phase 3 Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous PemphigoidTerminatedNCT05681481Phase 3Results posted
- A Phase 2/3 Study of Efgartigimod PH20 SC in Adult Participants With Bullous PemphigoidCompletedNCT05267600Phase 2/3Results posted
- A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid.TerminatedNCT04612790Phase 3Results posted
- A Study to Assess the Therapeutic Effect and Safety of Adjunctive AKST4290 in Subjects With Bullous PemphigoidTerminatedNCT04499235Phase 2Results posted
- A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous PemphigoidCompletedNCT04206553Phase 2/3Results posted
- Ixekizumab in the Treatment of Bullous PemphigoidCompletedNCT03099538Phase 2Results posted
- Evaluation of Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Bullous PemphigoidCompletedNCT02226146Phase 2Results posted
- Safety, Efficacy and PK/PD of QGE031 vs. Placebo in Patients With Active Bullous Pemphigoid Despite Oral Steroid TreatmentTerminatedNCT01688882Phase 2Results posted
- Clinical Trial Evaluating Rituximab in Ocular Cicatricial PemphigoidCompletedNCT00584935Phase 1/2Results posted
- Efficacy and Safety of Omalizumab in Bullous PemphigoidCompletedNCT00472030Phase 4Results posted
- Rituximab in the Treatment of Patients With Bullous PemphigoidCompletedNCT00286325Phase 1/2Results posted
- Association Between Disease Severity and Clinical, Histopathological, and Eosinophilic Markers in Patients With Bullous Pemphigoid (BP-EPIC)Active, not recruitingNCT07649486
- Prevalence of Sleep Disturbances in Bullous Pemphigoid Patients.CompletedNCT07188402
- JAK Inhibitors' Efficacy in Bullous PemphigoidCompletedNCT06561256
- Efficacy and Safety of add-on Dapsone Versus add-on Methotrexate in Patients With Bullous PemphigoidCompletedNCT05984381Phase 4
- Compassionate Use of Dupilumab for Adult Patients With Bullous PemphigoidApproved for marketingNCT05906706
- Efficacy and Safety of Dupilumab in Patients With Bullous PemphigoidCompletedNCT05649579
- Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous PemphigoidStatus unknownNCT05594472Phase 3
- Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.Active, not recruitingNCT05520086Phase 1/2
- Human Leukocyte Antigen Class II (DRB1 and DQB1) Alleles and Haplotypes Frequencies in Patients With Pemphigus Vulgaris Among the Russian PopulationStatus unknownNCT05284929
- Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP)WithdrawnNCT05061771Phase 3
- Telederm and Bullous PemphigoidCompletedNCT04728854
- Bullous Pemphigoid Induced by antiPD-1/PDL-1 TherapyStatus unknownNCT04641884
- Treatment of Bullous Pemphigoid With Avdoralimab (IPH5401), an Anti-C5aR1 Monoclonal AntibodyCompletedNCT04563923Phase 2
- Study of the Periodontal Microbiota in Gingival Cicatricial Pemphigoid Patients. Bicentric Pilot Study.CompletedNCT04555681
- The Association of Bullous Pemphigoid With Dipeptidyl-peptidase 4 InhibitorsStatus unknownNCT04469582
- The Effects of Tildrakizumab in Treatment of Bullous PemphigoidStatus unknownNCT04465292Early Phase 1
- Efficacy and Safety of Rituximab Combined With Omalizumab in Patients With Bullous PemphigoidWithdrawnNCT04128176Phase 3
- Efficacy and Safety of Ustekinumab in Bullous PemphigoidCompletedNCT04117932Phase 2
- rVA576 in Adult Mild to Moderate Bullous Pemphigoid SubjectsCompletedNCT04035733Phase 2
- Influence of Dermocorticoids on Bone Mineral Density in Patients With Bullous PemphigoidCompletedNCT03926377Phase 4
- Cytokines in Blister Fluids of Bullous Pemphigoid (BP)CompletedNCT03856840
- Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development of Bullous Pemphigoid?Status unknownNCT03636763
- Impact of Neurological Diseases on the Prognosis of Bullous Pemphigoid: A Retrospective Study of 178 PatientsCompletedNCT03320798
- Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane PemphigoidActive, not recruitingNCT03295383Phase 3
- A Proof-of-Concept Study of Topical AC-203 in Patients With Bullous PemphigoidTerminatedNCT03286582Phase 2
- Clinical Characteristics of Pruritus and Evaluation of Quality of Life in Patients With Bullous PemphigoidCompletedNCT03272958
- Interest of Dosage of Anti-PB230, Anti-PB180 and Cytokines for Monitoring of Patients Suffering From Bullous PemphigoidCompletedNCT02883894
- Genetic Susceptibility and Influence of the Microbiomae in Bullous PemphigoidStatus unknownNCT02874079Not applicable
- Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous PemphigoidCompletedNCT02837965
- Pruritus and Pemphigoid in Nursing Home PatientsCompletedNCT02823067
- Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated DisordersCompletedNCT02502903Phase 1
- Wound Dressings for Pemphigus and PemphigoidStatus unknownNCT02365675Not applicable
- Evaluation of Fluid Retention Due to Superpotent Topical CorticosteroidCompletedNCT02360202Phase 4
- Topical Steroids Alone or Associated With Methotrexate in Bullous PemphigoidCompletedNCT02313870Phase 3
- The Improvement of Limbal Epithelial Culture Technique by Using Collagenase to Isolate Limbal Stem CellsStatus unknownNCT02202642Phase 1
- Anti-IL-5 Therapy in Bullous Pemphigoid (BP)CompletedNCT01705795Phase 2
- Pilot Efficacy and Safety Study of Oral DF2156A in Patients With Active Bullous PemphigoidTerminatedNCT01571895Phase 2
- Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous PemphigoidTerminatedNCT01559155
- Phase III Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to CorticosteroidsCompletedNCT01408550Phase 3
- Explore the Mechanisms of Pruritus in Bullous Pemphigoid Patients During RemissionStatus unknownNCT01265082
- Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids.CompletedNCT00809822Phase 2
- Leflunomide Associated With Topical Corticosteroids for Bullous PemphigoidStatus unknownNCT00802243Phase 2
- Efficiency and Tolerance of Rituximab (mabthéra) in Bullous PemphigoidCompletedNCT00525616Phase 3
- Azathioprine or Mycophenolate Mofetil for Bullous PemphigoidCompletedNCT00431119Phase 2
- Comparison of Two Therapeutic Strategies of Dermoval in Treatment of Bullous PemphigusCompletedNCT00213421